All the other drugs targeting PI3K or Akt displayed an IC50 ranging from 3.2 to ≥ 10 μM for ALL-SIL and > 10 μM in PEER and BE-13 cells, respectively (Figure 2). This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.